Renal graft loss in recipients with at least one year of function and donor specific antibody (DSA)
Cicciarelli, J.; Shah, T.; Koss, M.; Houston, K.; Narahghi, R.
Clinical Transplants 2006: 539-540
2006
ISSN/ISBN: 0890-9016 PMID: 18365421 Document Number: 603408
Document emailed within 1 workday
Related Documents
Kumar, M.S.; Stephan, R.; Chui, J.; Chvala, R.P.; Olshan, A.; Krevolin, L.; Abouna, G.M. 1993: Effect of donor age on graft function and graft survival in cadaver renal transplantation Transplantation Proceedings 25(3): 2183-2184Morad, Z.; Suleiman, A.B.; Kong, C.T. 1989: Hepatitis in renal transplant recipients with and without donor-specific blood transfusion Transplantation Proceedings 21(1 Pt 2): 1825-1826
Alfonso, J.; Gralla, J.; Klem, P.; Chan, L.; Wiseman, A.C.; Cooper, J.E. 2014: High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts Clinical Transplants 2014: 161-170
Decaux, A.; Alexandre, L.; Eschwège, P.; Richard, C.; Devictor, D.; Joseph, L.; Decaris, J.; Charpentier, B.; Benoit, G. 1996: Does epinephrine administered in donor resuscitation influence graft renal function in the recipient? Transplantation Proceedings 28(5): 2889
Shoskes, D.A.; Hodge, E.E.; Goormastic, M.; Goldfarb, D.A.; Novick, A.C. 1995: HLA matching determines susceptibility to harmful effects of delayed graft function in renal transplant recipients Transplantation Proceedings 27(1): 1068-1069
Ettenger, R.B.; Opelz, G.; Walker, J.; Terasaki, P.I.; Malekzadeh, M.H.; Pennisi, A.J.; Uittenbogaart, C.H.; Fine, R.N. 1978: Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients Transplantation Proceedings 10(2): 479-481
Cosio, F.G.; Elkhammas, E.A.; Henry, M.L.; Pesavento, T.E.; Sedmak, D.D.; Pelletier, R.P.; Bumgardner, G.L.; Ferguson, R.M. 1998: Function and survival of renal allografts from the same donor transplanted into kidney-only or kidney-pancreas recipients Transplantation 65(1): 93-99
Blazar, B.R.; Taylor, P.A.; Fitzsimmons, W.E.; Vallera, D.A. 1994: FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation Journal of Immunology 153(4): 1836-1846
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Donaldson, P.T.; Thomson, L.J.; Heads, A.; Underhill, J.A.; Vaughan, R.W.; Rolando, N.; Williams, R. 1995: IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry Transplantation 60(9): 1016-1023
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343
van Besouw, N.M.; Daane, C.R.; Vaessen, L.M.; Mochtar, B.; Balk, A.H.; Weimar, W. 1997: Donor-specific cytokine production by graft-infiltrating lymphocytes induces and maintains graft vascular disease in human cardiac allografts Transplantation 63(9): 1313-1318
Yasunaga, C.; Cramer, D.V.; Chapman, F.A.; Wang, H.K.; Barnett, M.; Wu, G.D.; Makowka, L. 1993: Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium Transplantation Proceedings 25(3 Suppl. 2): 65-66
Pollard, S.G.; Davies, H.S.; Mason, J.L.; Caine, R.Y. 1989: High levels of donor HLA antigens in the circulation of human liver graft recipients Transplantation Proceedings 21(1 Part 1): 425-426
Gautreau, C.; Suberbielle, C.; Andrade, J.; Charron, D. 2006: Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation Clinical Transplants 2006: 502
Barrero Candau, R.; Morcillo Azcárate, J.; Fernández Hurtado, M.; García Merino, F.; de Agustín Asensio, J.C. 2010: Results of living donor kidney transplant in pediatric recipients, with graft obtained by laparoscopy Cirugia Pediatrica: Organo Oficial de la Sociedad Espanola de Cirugia Pediatrica 23(3): 141-143
Rush, D.N.; Jeffery, J.R.; Gough, J. 1995: Sequential protocol biopsies in renal transplant patients: repeated inflammation is associated with impaired graft function at 1 year Transplantation Proceedings 27(1): 1017-1018
Ijzermans, J.N.; Bouwman, E.; Jeekel, J.; Marquet, R.L. 1990: Donor pretreatment with IFN-gamma enhances MHC class Ii antigen expression and accelerates graft rejection by modified recipients Transplantation Proceedings 22(4): 1941-1942
Busquets, J.; Xiol, X.; Figueras, J.; Jaurrieta, E.; Torras, J.; Ramos, E.; Rafecas, A.; Fabregat, J.; Lama, C.; Ibañez, L.; Llado, L.; Ramon, J.M. 2001: The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival Transplantation 71(12): 1765-1771
Hard, R.C.; Carter, W.H.; Bick, P.H. 1983: Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease Journal of Immunology 131(6): 2623-2629